Prelaj, A.; Ferrara, R.; Rebuzzi, S.E.; Proto, C.; Signorelli, D.; Galli, G.; De Toma, A.; Randon, G.; Pagani, F.; Viscardi, G.;
et al. EPSILoN: A Prognostic Score for Immunotherapy in Advanced Non-Small-Cell Lung Cancer: A Validation Cohort. Cancers 2019, 11, 1954.
https://doi.org/10.3390/cancers11121954
AMA Style
Prelaj A, Ferrara R, Rebuzzi SE, Proto C, Signorelli D, Galli G, De Toma A, Randon G, Pagani F, Viscardi G,
et al. EPSILoN: A Prognostic Score for Immunotherapy in Advanced Non-Small-Cell Lung Cancer: A Validation Cohort. Cancers. 2019; 11(12):1954.
https://doi.org/10.3390/cancers11121954
Chicago/Turabian Style
Prelaj, Arsela, Roberto Ferrara, Sara Elena Rebuzzi, Claudia Proto, Diego Signorelli, Giulia Galli, Alessandro De Toma, Giovanni Randon, Filippo Pagani, Giuseppe Viscardi,
and et al. 2019. "EPSILoN: A Prognostic Score for Immunotherapy in Advanced Non-Small-Cell Lung Cancer: A Validation Cohort" Cancers 11, no. 12: 1954.
https://doi.org/10.3390/cancers11121954
APA Style
Prelaj, A., Ferrara, R., Rebuzzi, S. E., Proto, C., Signorelli, D., Galli, G., De Toma, A., Randon, G., Pagani, F., Viscardi, G., Brambilla, M., Trevisan, B., Ganzinelli, M., Martinetti, A., Gallucci, R., Di Mauro, R. M., Molino, G., Zilembo, N., Torri, V.,
... Lo Russo, G.
(2019). EPSILoN: A Prognostic Score for Immunotherapy in Advanced Non-Small-Cell Lung Cancer: A Validation Cohort. Cancers, 11(12), 1954.
https://doi.org/10.3390/cancers11121954